Oncotarget Strategies For Herpes Simplex Virus-1

E-ISSN： 1875-5631|16|2|130-143

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.16, Iss.2, 2016-04, pp. : 130-143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Corneal latency and transmission of herpes simplex virus-1

By Farooq Asim V Shukla Deepak

Future Virology, Vol. 6, Iss. 1, 2011-01 ,pp. : 101-108

Future Medicine

Access to resources Recommend Favorite

Novel agents and strategies to treat herpes simplex virus infections

By Kleymann Gerald

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 165-183

Informa Healthcare

Access to resources Recommend Favorite

Agents and strategies in development for improved management of herpes simplex virus infection and disease

By Kleymann Gerald

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 2, 2005-02 ,pp. : 135-161

Informa Healthcare

Access to resources Recommend Favorite

Prophylactic Vaccine Strategies and the Potential of Therapeutic Vaccines Against Herpes Simplex Virus

Current Pharmaceutical Design, Vol. 13, Iss. 19, 2007-07 ,pp. : 1975-1988

Bentham Science Publishers

Access to resources Recommend Favorite

Oncolytic Herpes Simplex Virus Type 1 and Host Immune Responses

Current Cancer Drug Targets, Vol. 7, Iss. 2, 2007-03 ,pp. : 149-155

Bentham Science Publishers

Access to resources Recommend Favorite